Literature DB >> 25146693

Measurement of statin exposure in the absence of information on prescribed doses.

Tomi Romppainen1, Maria Rikala, Emma Aarnio, Maarit Jaana Korhonen, Leena K Saastamoinen, Risto Huupponen.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25146693     DOI： 10.1007/s00228-014-1737-3

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  12 in total

1.  Statin usage and all-cause and disease-specific mortality in a nationwide study.

Authors:  Jari Haukka; Leo Niskanen; Timo Partonen; Jouko Lönnqvist; Jari Tiihonen
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-09-29       Impact factor: 2.890

2.  Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures.

Authors:  Lisa M Hess; Marsha A Raebel; Douglas A Conner; Daniel C Malone
Journal:  Ann Pharmacother       Date:  2006 Jul-Aug       Impact factor: 3.154

Review 3.  Methods for evaluation of medication adherence and persistence using automated databases.

Authors:  Susan E Andrade; Kristijan H Kahler; Feride Frech; K Arnold Chan
Journal:  Pharmacoepidemiol Drug Saf       Date:  2006-08       Impact factor: 2.890

4.  Frequency and clinical relevance of drug interactions with lovastatin and simvastatin: an observational database study.

Authors:  Tuire Tirkkonen; Anna Ryynänen; Tero Vahlberg; Kerttu Irjala; Timo Klaukka; Risto Huupponen; Kari Laine
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

5.  Comparison of various measures for assessing medication refill adherence using prescription data.

Authors:  N M Vink; O H Klungel; R P Stolk; P Denig
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-02       Impact factor: 2.890

Review 6.  The Nordic countries as a cohort for pharmacoepidemiological research.

Authors:  Kari Furu; Björn Wettermark; Morten Andersen; Jaana E Martikainen; Anna Birna Almarsdottir; Henrik Toft Sørensen
Journal:  Basic Clin Pharmacol Toxicol       Date:  2009-12-04       Impact factor: 4.080

7.  Statin adherence and the risk of major coronary events in patients with diabetes: a nested case-control study.

Authors:  Päivi Ruokoniemi; Maarit J Korhonen; Arja Helin-Salmivaara; Piia Lavikainen; Antti Jula; Seppo Y T Junnila; Raimo Kettunen; Risto Huupponen
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

8.  A comparison of two methods for estimating refill adherence to statins in Sweden: the RARE project.

Authors:  Eva Lesén; Tatiana Z Sandström; Anders Carlsten; Anna K Jönsson; Ann-Charlotte Mårdby; Karolina Andersson Sundell
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-08-19       Impact factor: 2.890

9.  Statins and hip fracture prevention--a population based cohort study in women.

Authors:  Arja Helin-Salmivaara; Maarit J Korhonen; Petri Lehenkari; Seppo Y T Junnila; Pertti J Neuvonen; Päivi Ruokoniemi; Risto Huupponen
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

10.  Frequency and predictors of tablet splitting in statin prescriptions: a population-based analysis.

Authors:  Colin R Dormuth; Sebastian Schneeweiss; Alan M Brookhart; Greg Carney; Ken Bassett; Stephen Adams; James M Wright
Journal:  Open Med       Date:  2008-08-12
View more
  8 in total

1.  Predictors of first-year nonadherence and discontinuation of statins among older adults: a retrospective cohort study.

Authors:  Richard Ofori-Asenso; Jenni Ilomäki; Mark Tacey; Si Si; Andrea J Curtis; Ella Zomer; J Simon Bell; Sophia Zoungas; Danny Liew
Journal:  Br J Clin Pharmacol       Date:  2018-11-08       Impact factor: 4.335

2.  Methods for constructing treatment episodes and impact on exposure-outcome associations.

Authors:  Laura Pazzagli; Lena Brandt; Marie Linder; David Myers; Panagiotis Mavros; Morten Andersen; Shahram Bahmanyar
Journal:  Eur J Clin Pharmacol       Date:  2019-11-22       Impact factor: 2.953

3.  Patient-Associated Characteristics Influencing the Risk for Non-Persistence with Statins in Older Patients with Peripheral Arterial Disease.

Authors:  Martin Wawruch; Gejza Wimmer; Jan Murin; Martina Paduchova; Tomas Tesar; Lubica Hlinkova; Peter Slavkovsky; Lubomira Fabryova; Emma Aarnio
Journal:  Drugs Aging       Date:  2019-09       Impact factor: 3.923

4.  Childhood adversity as a predictor of non-adherence to statin therapy in adulthood.

Authors:  Maarit Jaana Korhonen; Jaana I Halonen; M Alan Brookhart; Ichiro Kawachi; Jaana Pentti; Hasse Karlsson; Mika Kivimäki; Jussi Vahtera
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

Review 5.  Methods for time-varying exposure related problems in pharmacoepidemiology: An overview.

Authors:  Laura Pazzagli; Marie Linder; Mingliang Zhang; Emese Vago; Paul Stang; David Myers; Morten Andersen; Shahram Bahmanyar
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-12-28       Impact factor: 2.890

6.  Statin discontinuation in persons with and without Alzheimer's disease.

Authors:  Mai Vu; Raimo Kettunen; Anna-Maija Tolppanen; Sirpa Hartikainen; Heidi Taipale
Journal:  Eur J Clin Pharmacol       Date:  2022-04-21       Impact factor: 3.064

7.  Statin adherence and risk of acute cardiovascular events among women: a cohort study accounting for time-dependent confounding affected by previous adherence.

Authors:  Piia Lavikainen; Arja Helin-Salmivaara; Mervi Eerola; Gang Fang; Juha Hartikainen; Risto Huupponen; Maarit Jaana Korhonen
Journal:  BMJ Open       Date:  2016-06-03       Impact factor: 2.692

8.  Drug exposure in register-based research-An expert-opinion based evaluation of methods.

Authors:  Antti Tanskanen; Heidi Taipale; Marjaana Koponen; Anna-Maija Tolppanen; Sirpa Hartikainen; Riitta Ahonen; Jari Tiihonen
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.